| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |